RVX Resverlogix Corp.

0.0524USD0.0750 CAD · TSX0.00%Mkt Cap: 18.05M USDP/E: —

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal…